Feasibility and tolerance of sequential chemoradiotherapy in squamous cell carcinoma of the head and neck.

about

Feasibility and tolerance of sequential chemoradiotherapy in squamous cell carcinoma of the head and neck.

Item

http://www.wikidata.org/entity/Q43650000

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Feasibility and tolerance of s ...... arcinoma of the head and neck.

@en

Feasibility and tolerance of s ...... arcinoma of the head and neck.

@nl

type

Item

label

Feasibility and tolerance of s ...... arcinoma of the head and neck.

@en

Feasibility and tolerance of s ...... arcinoma of the head and neck.

@nl

prefLabel

Feasibility and tolerance of s ...... arcinoma of the head and neck.

@en

Feasibility and tolerance of s ...... arcinoma of the head and neck.

@nl

P1476

Feasibility and tolerance of s ...... arcinoma of the head and neck.

@en

P2093

C Martin

http://www.w3.org/2001/XMLSchema#string

K Geropantas

http://www.w3.org/2001/XMLSchema#string

S W Loo

http://www.w3.org/2001/XMLSchema#string

T W Roques

http://www.w3.org/2001/XMLSchema#string

Z Tasigiannopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical evidence for tumor clonogen regeneration: interpretations of the data.

Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases.

Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Completion of radiotherapy for local and regional head and neck cancer in medicare.

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

P304

32-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2354.2012.01352.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22519981

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy